Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04716920 · ClinicalTrials.gov registry record · NA
Tai Chi for Relieving Aromatase Inhibitor-Induced Arthralgia in Patients With Stage I-III Breast Cancer, the TaiChi4Joint Trial
A NA study, sponsored by Thomas Jefferson University.
- Completed
- Registry status
- NA
- Development phase
- 39
- Enrollment target
NCT04716920 is a NA study that has completed, run by Thomas Jefferson University. The registered enrollment target is 39 participants.
The verdict
NCT04716920, a NA study, has completed, sponsored by Thomas Jefferson University.
- COMPLETED
- Registry status
- NA
- Development phase
- 39 participants
- Enrollment target
Study Summary
This trial studies new methods using Tai Chi for the relief of joint pain (arthralgia) caused by an aromatase inhibitor in patients with stage I-III breast cancer. Tai Chi is a mind-body therapy that integrates moderate physical activity, deep breathing and meditation. Tai Chi may help to reduce aromatase inhibitor-induced joint pain, and offer a promising approach to managing symptoms in cancer patients.
Interventions
- OTHER Quality-of-Life Assessment
- OTHER Tai Chi
- OTHER Questionnaire Administration
- DEVICE FitBit
- OTHER Support Group Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2020-03-11 |
| Est. Completion | 2021-12-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04716920
The ClinicalTrials.gov registry entry for NCT04716920 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Thomas Jefferson University, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Quality-of-Life Assessment is the first listed.
NCT04716920 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04716920 about?
NCT04716920 is a clinical study titled "Tai Chi for Relieving Aromatase Inhibitor-Induced Arthralgia in Patients With Stage I-III Breast Cancer, the TaiChi4Joint Trial". This trial studies new methods using Tai Chi for the relief of joint pain (arthralgia) caused by an aromatase inhibitor in patients with stage I-III breast cancer. Tai Chi is a mind-body therapy that integrates moderate physical activity, deep breathing and meditation. Tai Chi may help to reduce aro...
What is the current status of trial NCT04716920?
This trial is currently completed. It is a NA study. The enrollment target is 39 participants. The study started on 2020-03-11. Estimated completion is 2021-12-23.
What interventions are being tested in trial NCT04716920?
The interventions under investigation include: Quality-of-Life Assessment (OTHER), Tai Chi (OTHER), Questionnaire Administration (OTHER), FitBit (DEVICE), Support Group Therapy (OTHER).
Who is sponsoring clinical trial NCT04716920?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.